Liver Disease Archives - Page 2 of 3 - Xtalks

Wednesday, August 12, 2026 | 11am EDT: Accelerate Cell Culture Media Development with Automated Cell Analysis

Gilead’s Livdelzi (Seladelpar) for Primary Biliary Cholangitis Promises Pruritus Reduction

August 22, 2024

Healthcare News

First Successful Pediatric Liver Transplant with LIVERguard Donor Preservation System

New HCV Test Enables Diagnosis and Treatment in a Single Visit

Life Science Podcast

New Frontiers in MASH and Chronic Liver Diseases with Aligos CEO Dr. Lawrence Blatt

Iqirvo Breaks Decade-Long Hiatus in Primary Biliary Cholangitis Treatment Options

Madrigal Pharma’s Rezdiffra Gets Landmark Approval as First Treatment for Fatty Liver Disease NASH/MASH

Eli Lilly’s Tirzepatide Shows Promise in Treating Fatty Liver Disease

February 21, 2024

Incorporating the Patient’s Voice in NASH Clinical Trials

October 13, 2023

Updates in Cell and Gene Therapy: Current Trends and Operational Considerations

October 05, 2023

Non-Invasive Approaches to NAFLD/NASH Drug Development

Digital Pathology: Artificial Intelligence Models in Gastrointestinal Diseases

Terlivaz (terlipressin) Injection Gets FDA Approval to Treat Hepatorenal Syndrome

October 3, 2022

Time for Change in NASH: How Non-Invasive Biomarkers are Driving a Paradigm Shift in Clinical Trials and Clinical Care

October 27, 2022

NASH Populations with Cirrhosis: Drug Development Challenges and Solutions

February 16, 2022

Business & Finance News

NHS England Inks Deal with Big Pharma to Eliminate Hepatitis C Infections

Life Science News

Bioengineered Liver Tissue Could Reduce Reliance on Donors

December 7, 2017

Next Page »